Funding Rounds
Actimed Therapeutics

Actimed Therapeutics Series A (2023, $6M)

Actimed Therapeutics

Developer of innovative treatment for muscle wasting disorders.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $6.07M

Investors